Radioimmunotherapy in Refractory B-cell NonHodgkins Lymphoma with I-131-Labeled Chimeric Anti CD-20 C2B8 (I-131 rituximab): Preliminary Result

Kang, Hye-Jin (Internal Medicine, Korea Institute of Radiology and Medical Science) ;
Park, Yeon-Hee (Internal Medicine, Korea Institute of Radiology and Medical Science) ;
Kim, Sung-Eun (Division of Hematology of Oncology, Korea Institute of Radiology and Medical Science) ;
Chon, Gi-Jeong (Nuclear Medicines, Korea Institute of Radiology and Medical Science) ;
Choi, Chang-Woon (Nuclear Medicines, Korea Institute of Radiology and Medical Science) ;
Lim, Sang-Moo (Nuclear Medicines, Korea Institute of Radiology and Medical Science) ;
Lee, Seung-Sook (Pathology, Korea Institute of Radiology and Medical Science) ;
Kim, Won-Suk (Department of Nuclear Medicine, Korea University Medical School) ;
Kim, Ki-Hyun (Department of Nuclear Medicine, Korea University Medical School) ;
Bang, Soo-Mee (Division of Hematology-Oncology, Korea University Medical School) ;
Yuh, Young-Jin ;
Na, Im-Il (Internal Medicine, Korea Institute of Radiology and Medical Science) ;
Ryoo, Baek-Yeol (Internal Medicine, Korea Institute of Radiology and Medical Science)